Most sedating antipsychotics, ranked

Ranking (most to least sedating in typical clinical use)

Very high sedation:

• Chlorpromazine (Thorazine): strong H1, alpha-1, and M1 antagonism. Legendarily sedating.
• Quetiapine (Seroquel): potent H1 antagonism. Even at very low doses (25 to 50 mg) causes substantial sedation, which is why it's often prescribed off-label as a sleep aid (a use that isn't a great fit for the drug's risk profile).
• Clozapine (Clozaril): strong H1 and M1 antagonism. Sedation is often the first side effect and can be dose-limiting during titration.

High sedation:

• Olanzapine (Zyprexa): potent H1 antagonism. Dose-related.
• Mesoridazine, thioridazine: rarely used now due to QT concerns.
• Perphenazine (Trilafon): moderate at typical doses.

Moderate sedation:

• Asenapine (Saphris) at low doses; more sedating at higher doses.
• Risperidone (Risperdal): variable, some patients report substantial sedation, others none.
• Iloperidone (Fanapt): dose-related.
• Ziprasidone (Geodon): variable; taken with food which affects absorption timing.

Low to minimal sedation:

• Aripiprazole (Abilify): often described as "activating" rather than sedating, with some patients reporting insomnia or restlessness.
• Brexpiprazole (Rexulti): similar activating profile.
• Cariprazine (Vraylar): activating profile.
• Lurasidone (Latuda): activating, requires food for absorption.
• Lumateperone (Caplyta): minimal sedation at 42 mg approved dose.
• Cobenfy (xanomeline-trospium): minimal sedation in EMERGENT trials.

Why sedation happens

Three receptor systems drive antipsychotic sedation:

H1 (histamine) antagonism is the primary driver. Blocking H1 in the CNS causes the same sedation caused by first-generation antihistamines (diphenhydramine, hydroxyzine). The most sedating antipsychotics all have strong H1 antagonism.

Alpha-1 adrenergic antagonism contributes via reduced arousal from noradrenergic tone. Also causes orthostatic hypotension.

M1 (muscarinic) antagonism adds to sedation and cognitive slowing. See anticholinergic burden for the full picture.

When sedation is desired

Some clinical scenarios use antipsychotic sedation intentionally:

• Acute agitation in psychosis: sedating antipsychotics rapidly reduce distressing agitation. Olanzapine is often chosen for this reason.
• Insomnia with prominent anxiety in bipolar disorder: quetiapine at low dose is sometimes prescribed, though off-label use for insomnia specifically has poor risk-benefit.
• Delirium with severe agitation: sedating antipsychotics have a role in the ICU or hospital setting.

When sedation is a problem

• Employed patients: any sedating antipsychotic during work hours risks job loss.
• Students: impairs learning and performance.
• Older adults: increases fall risk and cognitive impairment.
• Driving: dose-dependent impairment.

Managing sedation

• Time the dose: taking the sedating antipsychotic at bedtime rather than morning is often the single best intervention.
• Reduce the dose: sedation is dose-related for most drugs. Lowest effective dose usually reduces sedation.
• Wait: for many drugs, sedation attenuates over 2 to 4 weeks as receptor adaptation occurs. Not universal.
• Switch: to a less sedating drug in the same class. Aripiprazole, cariprazine, lurasidone, and lumateperone are typical switch targets.

Common questions

Which antipsychotic is the least sedating? Cobenfy (xanomeline-trospium), lumateperone (Caplyta), lurasidone (Latuda), cariprazine (Vraylar), and aripiprazole (Abilify) are the least sedating. Many patients describe these as "activating" and may experience insomnia rather than sedation.

Is quetiapine really that sedating even at low doses? Yes. Quetiapine has high H1 affinity relative to D2 affinity. At 25 to 100 mg, the H1 effect dominates and the drug is primarily sedating without much antipsychotic action. This is why it's sometimes prescribed off-label as a sleep aid, though the risk-benefit of chronic quetiapine for insomnia is generally poor compared to other sleep options.

Why does olanzapine make me so tired? Strong H1 antagonism plus alpha-1 antagonism plus modest muscarinic effect. Olanzapine sedation is often dose-limiting during titration and frequently the reason patients switch to a different drug. Sedation is worst in the first 2 to 4 weeks and often improves modestly with continued treatment.

Does taking the antipsychotic at night help? Yes, for most sedating drugs. Once-daily bedtime dosing lets patients sleep through the peak sedation. This works for quetiapine, olanzapine, risperidone, and most others.

Is antipsychotic sedation permanent? Usually no. Sedation attenuates over weeks to months for many patients as receptors adapt. Some patients continue to have sedation as a chronic side effect, particularly on olanzapine, clozapine, or high-dose quetiapine.

Which antipsychotic causes insomnia instead of sedation? Aripiprazole (Abilify) is the most commonly cited. Cariprazine, brexpiprazole, and lurasidone can also cause insomnia. These partial agonists have different receptor profiles and often produce activation rather than sedation.

Related

• Anticholinergic burden
• Atypical antipsychotics class overview
• Antipsychotic CPZ equivalent calculator
• Switching antipsychotics guide

Sources

• Leucht S, Cipriani A, Spineli L, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet. 2013;382(9896):951-962.
• Huhn M, Nikolakopoulou A, Schneider-Thoma J, et al. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet. 2019;394(10202):939-951.
• FDA prescribing information for individual drugs via DailyMed.